No abstract available
MeSH terms
-
Angiogenesis Inhibitors / economics*
-
Angiogenesis Inhibitors / therapeutic use
-
Antibodies, Monoclonal, Humanized / economics*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Bevacizumab
-
Drug Approval
-
Drug Costs
-
Drug Design
-
Humans
-
Italy
-
Macular Degeneration / drug therapy*
-
Macular Degeneration / economics
-
Macular Degeneration / physiopathology
-
Off-Label Use
-
Ranibizumab
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Ranibizumab